5 results Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types. Louis Bidaine Associate Brussels The latest Legal Updates straight to your mailbox We publish high-quality legal knowledge and insights on our website on a daily basis. If you would like to be promptly informed about the latest developments within your areas of interest, we invite you to sign up for our Legal Updates. Stibbe advises SleepScore Labs Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company. Legal Considerations for Artificial Intelligence in the Life Sciences Sector This blogpost explores the evolving legal landscape governing AI in life sciences, with a focus on medical device regulation, data protection and intellectual property.
Temporary authorisations for certain biocidal products to tackle the Corona crisis: unusual times call for unusual (temporary) measures The outbreak of the Covid-19 crisis has been officially acknowledged as a pandemic and public health crisis. In response, the Belgian authorities have decided to proceed with the grant of temporary authorisations for certain biocidal product types.
The latest Legal Updates straight to your mailbox We publish high-quality legal knowledge and insights on our website on a daily basis. If you would like to be promptly informed about the latest developments within your areas of interest, we invite you to sign up for our Legal Updates.
Stibbe advises SleepScore Labs Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company.
Legal Considerations for Artificial Intelligence in the Life Sciences Sector This blogpost explores the evolving legal landscape governing AI in life sciences, with a focus on medical device regulation, data protection and intellectual property.